LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,502,755 | -31.7% | 186,136 | -29.8% | 0.01% | -31.6% |
| Q2 2023 | $18,304,340 | +214.8% | 265,165 | +119.9% | 0.02% | +216.7% |
| Q1 2023 | $5,813,789 | -71.1% | 120,568 | -70.1% | 0.01% | -72.7% |
| Q4 2022 | $20,117,610 | -4.0% | 402,997 | -21.5% | 0.02% | -12.0% |
| Q3 2022 | $20,946,000 | +207.4% | 513,389 | +314.4% | 0.02% | +212.5% |
| Q2 2022 | $6,814,000 | -48.6% | 123,890 | -66.1% | 0.01% | -33.3% |
| Q1 2022 | $13,261,000 | -34.3% | 364,922 | -15.7% | 0.01% | -29.4% |
| Q4 2021 | $20,187,000 | +24.6% | 433,096 | +35.2% | 0.02% | +13.3% |
| Q3 2021 | $16,195,000 | +99.7% | 320,309 | +62.2% | 0.02% | +114.3% |
| Q2 2021 | $8,108,000 | – | 197,513 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |